MONCTON, New Brunswick and CAMBRIDGE, Mass., February 25, 2025 – Breathe BioMedical, a company developing a breath analytics platform for early disease detection, today announced the launch of its first large multi-center observational collection…
Moncton, New Brunswick–(February 19, 2025) – Breathe Biomedical Inc (Private) (“Breathe” or the “Company“), a company developing a breath analytics platform for early disease detection, is pleased to announce it will be presenting at…
MONCTON, NB, January 9th, 2024 – Breathe BioMedical (BBM) is pleased to announce the appointment of Dr. Rachel Brem to the company’s Board of Directors in her newly appointed role of Executive Director and Chief Medical Officer.…
MONCTON, NB, September 5th, 2023 – Breathe BioMedical (BBM) has announced Bill Dawes as their new Chief Executive Officer (CEO), effective August 14, 2023. Bill has served as the Chief Business Officer (CBO) at BBM over the last two…
MONCTON, NB, May 26th, 2023 – Breath biomarkers demonstrate high accuracy in detecting early-stage breast cancer in women with dense breast tissue. Innovative research using Breathe BioMedical’s breath analytics technology has shown promising results…
MONCTON, NB, October 18th, 2022 – Dr. Farah Naz and Donna Fairweather RN of New Brunswick’s Horizon Health Network completed a preliminary analysis for a study with Breathe BioMedical’s technology at the Saint John…
MONCTON, NB, May 31st, 2022 – Breathe BioMedical is pleased to announce the appointment of Don Hardison to the Board of Directors. Don has extensive leadership experience in executive positions as President and CEO…
